Testing effectiveness (Phase 2)Study completedNCT00259987
What this trial is testing
Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
Who this might be right for
Adenocarcinoma
GlaxoSmithKline 24
Showing 19 of 19 results